טוען...

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study

Background: Overweight and obesity are predisposing conditions for the development of prediabetes and type 2 diabetes. Insulin resistance caused by excess adiposity is a key factor in this process. Methods: The effect of Gelesis100, a novel hydrogel, was assessed in patients who were overweight or h...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Endocr Soc
Main Authors: Greenway, Frank, Fujioka, Ken, Luzi, Livio, Svacina, Stepan, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Gnessi, Lucio, Navas-Carretero, Santiago, Martinez, J., Apovian, Caroline, Hill, James, Kaplan, Lee, Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
פורמט: Artigo
שפה:Inglês
יצא לאור: Endocrine Society 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550777/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-112
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!